Cardiovascular & Metabolic Diseases
Breath biomarkers could lead to non-invasive detection and monitoring for liver disease, diabetes, kidney disease, heart failure and other cardiovascular and metabolic diseases
Find out more
Webinar: Developing EVOC Probes for liver disease
As part of BBCon21, Giuseppe Ferrandino presents our work developing exogenous VOC probes for high sensitivity, high contrast detection of liver disease using breath
View Presentation
Article: Insights into potential VOC biomarkers of diabetes
Non-invasive breath testing offers an attractive alternative to currently available diabetes tests for diagnosis and ongoing monitoring
Read Review
Article: Examining candidate breath biomarkers for kidney disease
A non-invasive breath test could allow for cheaper screening and earlier intervention, when damage is less severe
View Publication
Case Study: Could acetone be a biomarker of heart failure?
Current biomarkers of heart function are very invasive but evidence suggests breath acetone could be useful for both diagnosis and prognosis
Read Case study
We’ve worked on cardiovascular and metabolic disease with these groups:
 |
 |
 |
Recommended reading:
- POSTER: Pre-clinical in vitro VOC analysis to identify biomarker candidates for chronic liver diseases detection – A Breath Biopsy study.
- PAPER: Targeted breath analysis: exogenous volatile organic compounds (EVOC) as metabolic pathway-specific probes
- REVIEW: Could breath acetone be a potentially useful biomarker for heart failure?
- POSTER: Comparing cirrhosis and liver cancers – A Breath Biopsy study with Cleveland Clinic proposing ketones and terpenes as possible biomarkers of chronic liver diseases
- DOWNLOAD: Breath Biopsy: The Complete Guide – Over 100 pages packed with everything you need to know about breath research, and the applications and technologies of Breath Biopsy.
- PAPER: Volatile Biomarkers in Breath Associated With Liver Cirrhosis – Comparisons of Pre- and Post-liver Transplant Breath Samples.
